Nautilus生物技术公司收到纳斯达克退市通知Nautilus Biotechnology Receives Delisting Notice From Nasdaq

动脉网2025-05-05

NEW YORK – Proteomics firm Nautilus Biotechnology said Friday that it has received notification from the Nasdaq that its common stock bid price has closed below the required minimum of $1.00 per share...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2533584984?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-05 20:57","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2533584984","market":"us","top_or_hot":-1,"title":"Nautilus生物技术公司收到纳斯达克退市通知Nautilus Biotechnology Receives Delisting Notice From Nasdaq","media":"动脉网","content":"<div>\n<p>NEW YORK – Proteomics firm Nautilus Biotechnology said Friday that it has received notification from the Nasdaq that its common stock bid price has closed below the required minimum of $1.00 per share...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050520581194eced14&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nautilus生物技术公司收到纳斯达克退市通知Nautilus Biotechnology Receives Delisting Notice From Nasdaq</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNautilus生物技术公司收到纳斯达克退市通知Nautilus Biotechnology Receives Delisting Notice From Nasdaq\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-05 20:57 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050520581194eced14&s=b><strong>动脉网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NEW YORK – Proteomics firm Nautilus Biotechnology said Friday that it has received notification from the Nasdaq that its common stock bid price has closed below the required minimum of $1.00 per share...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050520581194eced14&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NVIW.SI","symbol_name":"NVDA 3xLongSG261006","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050520581194eced14&s=b","article_id":"2533584984","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050520581194eced14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2533584984","pubTimestamp":1746449820,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"NEW YORK – Proteomics firm Nautilus Biotechnology said Friday that it has received notification from the Nasdaq that its common stock bid price has closed below the required minimum of $1.00 per share for the last 30 consecutive business days.纽约——蛋白质组学公司Nautilus生物技术公司周五表示，已收到纳斯达克的通知，称其普通股出价在过去连续30个交易日中已低于每股1.00美元的最低要求。In accordance with Nasdaq rules, the company now has 180 calendar days, or until Oct. 28, to regain compliance with the minimum bid price requirement. To do so, Nautilus's stock must maintain a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days during that period..根据纳斯达克规则，该公司现在有180个日历日，或直到10月28日，以重新遵守最低出价要求。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"NVIW.SI":"NVDA 3xLongSG261006","TSYW.SI":"TESLA 3xLongSG261006",".IXIC":"NASDAQ Composite","USJW.SI":"ALPHAB 3xLongSG261006","PSQ":"做空纳斯达克100指数ETF-ProShares","BK4121":"生命科学工具和服务","NAUT":"Nautilus Biotechnolgy, Inc.","BK4007":"制药","USAW.SI":"AMZN 3xLongSG261006","QLD":"2倍做多纳斯达克100指数ETF-ProShares","TQQQ":"纳指三倍做多ETF","ARTL":"Artelo Biosciences, Inc.","SQQQ":"纳指三倍做空ETF","QID":"两倍做空纳斯达克指数ETF-ProShares"},"translate_title":"Nautilus Biotechnology Receives Delisting Notice From Nasdaq Nautilus Biotechnology Receives Delisting Notice From Nasdaq","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVIW.SI":0.6,"USAW.SI":0.6,"MNQmain":0.6,"SQQQ":0.6,"TQQQ":0.6,"PSQ":0.6,"QID":0.6,"TSYW.SI":0.6,"NQmain":0.6,"ARTL":1,".IXIC":1,"USJW.SI":0.6,"QLD":0.6,"NAUT":0.9},"content_text":"NEW YORK – Proteomics firm Nautilus Biotechnology said Friday that it has received notification from the Nasdaq that its common stock bid price has closed below the required minimum of $1.00 per share for the last 30 consecutive business days.纽约——蛋白质组学公司Nautilus生物技术公司周五表示，已收到纳斯达克的通知，称其普通股出价在过去连续30个交易日中已低于每股1.00美元的最低要求。In accordance with Nasdaq rules, the company now has 180 calendar days, or until Oct. 28, to regain compliance with the minimum bid price requirement. To do so, Nautilus's stock must maintain a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days during that period..根据纳斯达克规则，该公司现在有180个日历日，或直到10月28日，以重新遵守最低出价要求。在此期间，Nautilus的股票必须保持至少10个连续交易日的收盘出价不低于每股1.00美元。If the company does not regain compliance during this period, it may be eligible for an additional 180-day period during which it can achieve compliance.如果公司在此期间未能重新遵守规定，它可能有资格获得额外的180天期限以实现合规。Nautilus is developing a single-molecule proteome analysis platform but has failed multiple times to hit development timelines and most recently鹦鹉螺公司正在开发一个单分子蛋白质组分析平台，但已多次未能按时完成开发计划，最近一次是pushed back推迟the projected launch of its system to late 2026. In February, the company laid off 16 percent of its staff in an effort to extend its cash runway.其系统预计推出时间推迟到2026年底。今年2月，该公司裁员16%，以延长其现金周转时间。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2533584984","isCrawlerRequest":true}